Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

Clinical lung cancer·2025

Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024

Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024

Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024

Same author

[Antimicrobial peptides: A new alternative for the treatment of aspergillosis].

Revue des maladies respiratoires·2024

Search research articles

Related Experiment Video

Updated: Oct 8, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiotherapy of lymphomas.

J Balosso¹, F Missohou¹, D Antoni²

¹Centre François-Baclesse, BP 45026, 14076 Caen cedex 5, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique

|December 26, 2021

Summary

Radiotherapy remains crucial for early-stage Hodgkin lymphoma, often combined with chemotherapy. Treatment personalization, guided by FDG-PET scans, aims to reduce toxicity while maintaining high cure rates and quality of life.

Keywords:

French society for radiation oncology Guidelines Hodgkin lymphoma Lymphome hodgkinien Lymphomes non hodgkiniens Non-Hodgkin lymphoma Radiation therapy Radiothérapie Recommandations Société française de radiothérapie oncologique

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Experiment Videos

Last Updated: Oct 8, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Area of Science:

Oncology
Radiation Oncology
Hematology

Background:

Radiotherapy is a cornerstone in managing early-stage Hodgkin lymphoma, frequently used alongside chemotherapy.
While its role in non-Hodgkin lymphomas is more limited, similar therapeutic principles apply across histological types.
Evolving strategies focus on optimizing treatment outcomes and patient quality of life.

Purpose of the Study:

To present an updated set of recommendations for radiotherapy in lymphoma management.
To highlight the evolving therapeutic strategies and evaluation methods in lymphoma radiotherapy.
To emphasize the importance of personalized treatment approaches based on diagnostic assessments.

Main Methods:

Review and update of clinical guidelines for radiotherapy in lymphomas.
Integration of findings from FDG-PET (fluorodeoxyglucose-positron emission tomography) assessments for treatment personalization.
Consideration of both Hodgkin and non-Hodgkin lymphoma treatment paradigms.

Main Results:

Radiotherapy plays a vital role in early-stage Hodgkin lymphoma, enhancing cure rates.
Personalized radiotherapy, informed by FDG-PET, allows for de-escalation of toxicity.
Updated recommendations reflect advancements in therapeutic strategies and evaluation.

Conclusions:

Radiotherapy remains integral to Hodgkin lymphoma treatment, particularly in early stages.
Personalized treatment de-escalation using FDG-PET is key to improving patient quality of life.
Continuous evolution in lymphoma radiotherapy necessitates regular guideline updates.